BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia

British Journal of Haematology

Volumn 162, Issue 6, 2013, Pages 848-851

  Akarca, Ayse U ^a   Shende, Vishvesh H ^a   Ramsay, Alan D ^b   Diss, Tim ^a   Pane Foix, Maria ^b   Rizvi, Hasan ^c   Calaminici, Maria R ^c   Grogan, Thomas M ^d   Linch, David ^e   Marafioti, Teresa ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Haematological malignancies; Immunocytochemistry; Leukaemia diagnosis

Indexed keywords

B RAF KINASE ANTIBODY; BIOLOGICAL MARKER; ENZYME ANTIBODY; GLUTAMIC ACID; MESSENGER RNA; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG; VALINE;

BRAF PROTO ONCOGENE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LETTER; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTO ONCOGENE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

HAEMATOLOGICAL MALIGNANCIES; IMMUNOCYTOCHEMISTRY; LEUKAEMIA DIAGNOSIS;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, HAIRY CELL; MUTATION; NEOPLASM, RESIDUAL; PROTO-ONCOGENE PROTEINS B-RAF; TUMOR MARKERS, BIOLOGICAL;

EID: 84883308696     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12429     Document Type: Letter

References (10)

1. Andrulis, M., Penzel, R., Weichert, W., von Deimling, A. & Capper, D. (2012) Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia. American Journal of Surgical Pathology, 36, 1796-1800.
2. Ascierto, P.A., Kirkwood, J.M., Grob, J.J., Simeone, E., Grimaldi, A.M., Maio, M., Palmieri, G., Testori, A., Marincola, F.M. & Mozzillo, N. (2012) The role of BRAF V600 mutation in melanoma. Journal of Translational Medicine, 10, 85.
3. Blombery, P.A., Wong, S.Q., Hewitt, C.A., Dobrovic, A., Maxwell, E.L. & Juneja, S. (2012) Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders. Haematologica, 97, 780-783.
4. Cantwell-Dorris, E.R., O'Leary, J.J. & Sheils, O.M. (2011) BRAFV600E: implications for carcinogenesis and molecular therapy. Molecular Cancer Therapeutics, 10, 385-394.
5. Dietrich, S., Glimm, H., Andrulis, M., von Kalle, C., Ho, A.D. & Zenz, T. (2012) BRAF inhibition in refractory hairy-cell leukemia. The New England Journal of Medicine, 366, 2038-2040.
6. Grever, M.R. (2010) How I treat hairy cell leukemia. Blood, 115, 21-28.
7. Laurini, J.A., Aoun, P., Iqbal, J., Chan, W. & Greiner, T.C. (2012) Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders. American Journal of Clinical Pathology, 138, 877-883.
8. Sahm, F., Capper, D., Preusser, M., Meyer, J., Stenzinger, A., Lasitschka, F., Berghoff, A.S., Habel, A., Schneider, M., Kulozik, A., Anagnostopoulos, I., Müllauer, L., Mechtersheimer, G. & von Deimling, A. (2012) BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood, 120, 28-34.
9. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Edn. IARC, Lyon.
10. Tiacci, E., Trifonov, V., Schiavoni, G., Homes, A., Kern, W. & Martelli, M.P. (2011) BRAF mutations in hairy-cell leukemia. The New England Journal of Medicine, 364, 2305-2315.